arrow
R

René Bernards

Netherlands Cancer Institute
H指数:111
被引数:7.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial

阿特珠单抗联合贝伐珠单抗在MSI-like转移性结直肠癌中的有效性和安全性:一项多中心、单臂、II期、开放标签临床试验

2025-12-020
OAAI
An antibiotic that mediates immune destruction of senescent cancer cells

一种介导衰老癌细胞免疫破坏的抗生素

2024-12-180
OAAI
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial

lenvatinib联合gefitinib在lenvatinib耐药的肝细胞癌中的疗效与安全性:一项前瞻性、单臂探索性试验

2024-12-090
OAAI
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities

癌症药物耐受性持久细胞: 从生物学问题到临床机会

2024-09-020
PRE
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024-03-266
OAAI
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse
2024-03-018
OAAI